Pharmacists asked to assist in switching patients from Promixin by end of April 2025
A national patient safety alert advises that Colicym 1-million-unit power for nebuliser solution unit dose vials should be considered as an alternative treatment.
The national patient safety alert said that as stocks of Colomycin are in short supply, this treatment should be reserved for existing patients and those who require the treatment intravenously
Shutterstock.com
Patients taking Promixin must be switched to an alternative by 30 April 2025, the Department of Health and Social Care (DHSC) and NHS England have said.
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.